Kevin Siebert plans Rule 144 Viavi (VIAV) share sale after prior insider sales

Rhea-AI Filing Summary

Viavi Solutions insider Kevin Siebert has filed a Rule 144 notice to sell 13,577 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NASDAQ, has an aggregate market value of $349,205.87. Shares outstanding were 231,389,345 common shares as of the filing.

In the past three months, Siebert sold 24,225 common shares on 12/08/2025 for gross proceeds of $442,280.67 and 11,148 common shares on 11/03/2025 for gross proceeds of $192,795.74. The shares to be sold were acquired from the issuer via performance share and restricted stock awards between 2019 and 2022.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13577	349205.87	231389345	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/23/2021	Performance Shares	Issuer			950	09/23/2021	Not Applicable
Common	05/28/2022	Restricted Stock	Issuer			293	05/28/2022	Not Applicable
Common	08/28/2021	Restricted Stock	Issuer			1140	08/28/2021	Not Applicable
Common	11/28/2021	Restricted Stock	Issuer			293	11/28/2021	Not Applicable
Common	08/28/2021	Restricted Stock	Issuer			293	08/28/2021	Not Applicable
Common	09/23/2021	Performance Shares	Issuer			431	09/23/2021	Not Applicable
Common	08/28/2022	Restricted Stock	Issuer			1140	08/28/2022	Not Applicable
Common	02/28/2021	Restricted Stock	Issuer			270	02/28/2021	Not Applicable
Common	09/26/2019	Performance Shares	Issuer			2059	09/26/2019	Not Applicable
Common	09/26/2019	Performance Shares	Issuer			1647	09/26/2019	Not Applicable
Common	08/28/2022	Restricted Stock	Issuer			967	08/28/2022	Not Applicable
Common	09/26/2019	Performance Shares	Issuer			1721	09/26/2019	Not Applicable
Common	02/28/2022	Restricted Stock	Issuer			270	02/28/2022	Not Applicable
Common	05/28/2021	Restricted Stock	Issuer			293	05/28/2021	Not Applicable
Common	09/23/2021	Performance Shares	Issuer			1517	09/23/2021	Not Applicable
Common	08/28/2022	Restricted Stock	Issuer			293	08/28/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KEVIN SIEBERT 1445 South Spectrum Blvd Suite 102 Chandler AZ 85286	Common	12/08/2025	24225	442280.67
KEVIN SIEBERT 1445 South Spectrum Blvd Suite 102 Chandler AZ 85286	Common	11/03/2025	11148	192795.74

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Rule 144 filing disclose for Viavi (VIAV)?

The filing discloses that insider Kevin Siebert plans to sell 13,577 Viavi common shares under Rule 144. The planned NASDAQ sale, through Morgan Stanley Smith Barney LLC, has an aggregate market value of $349,205.87 based on the figures in the notice.

How many Viavi (VIAV) shares is Kevin Siebert planning to sell?

Kevin Siebert plans to sell 13,577 shares of Viavi common stock under Rule 144. The notice lists an aggregate market value of $349,205.87 for this planned transaction, with Morgan Stanley Smith Barney LLC named as the broker handling the sale on NASDAQ.

What recent Viavi (VIAV) stock sales has Kevin Siebert reported?

The notice shows Siebert sold 24,225 common shares on 12/08/2025 for gross proceeds of $442,280.67 and 11,148 common shares on 11/03/2025 for $192,795.74. These transactions are reported as sales of Viavi common stock during the past three months.

How were the Viavi (VIAV) shares in this Rule 144 filing acquired?

The shares were acquired directly from the issuer via performance share and restricted stock awards between 2019 and 2022. The table lists multiple grants, including performance shares dated 09/26/2019 and 09/23/2021, and restricted stock awards on several 2021 and 2022 dates.

What is the share count context for Viavi (VIAV) in this filing?

The filing states that 231,389,345 shares of Viavi common stock were outstanding. This figure provides context for the 13,577-share planned sale reported, indicating the total number of common shares outstanding at the time referenced in the notice.

Which broker and exchange are used for the Viavi (VIAV) Rule 144 sale?

The planned Rule 144 sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The notice specifies that the 13,577 Viavi common shares are expected to be sold on the NASDAQ exchange, with an approximate sale date of 02/02/2026.